Medications for Postencephalitic Parkinson Disease

13 results

  • Amantadine hcl (amantadine hydrochloride)

    (AMANTADINE HYDROCHLORIDE)
    Bionpharma Inc.
    Usage: Amantadine Hydrochloride Capsules are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for managing parkinsonism and drug-induced extrapyramidal reactions. Prophylaxis assists immune response development, but it’s not a substitute for vaccination. Effectiveness for other viral illnesses is not established.

  • Carbidopa and levodopa (carbidopa and levodopa)

    (Carbidopa and Levodopa)
    A-S Medication Solutions
    Usage: Carbidopa and levodopa tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism due to carbon monoxide or manganese intoxication. Carbidopa allows lower levodopa doses, improving patient response and reducing nausea, facilitating quicker titration of levodopa.

  • Carbidopa and levodopa (carbidopa and levodopa)

    (Carbidopa and Levodopa)
    Alembic Pharmaceuticals Limited
    Usage: Carbidopa and levodopa extended-release tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism resulting from carbon monoxide or manganese intoxication.

  • Carbidopa and levodopa (carbidopa and levodopa)

    (Carbidopa and Levodopa)
    Physicians Total Care, Inc.
    Usage: Carbidopa and levodopa tablets are indicated for treating symptoms of idiopathic Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism after nervous system injury. This combination allows lower levodopa doses, reducing nausea and enabling smoother dose titration, but does not enhance levodopa's efficacy in parkinsonian syndromes.

  • Carbidopa and levodopa (carbidopa and levodopa)

    (Carbidopa and Levodopa)
    Dr. Reddy's Laboratories Inc.
    Usage: Carbidopa and levodopa tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism from carbon monoxide or manganese intoxication. They improve response to levodopa, reduce necessary dosing, and may decrease nausea, allowing for faster dose adjustments.

  • Carbidopa and levodopa (carbidopa and levodopa)

    (Carbidopa and Levodopa)
    A-S Medication Solutions
    Usage: Carbidopa and levodopa tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism following carbon monoxide or manganese intoxication. Carbidopa enhances the effectiveness of levodopa, allows for lower doses, and may reduce nausea and vomiting, facilitating more rapid dosage adjustments.

  • Carbidopa and levodopa (carbidopa and levodopa)

    (Carbidopa and levodopa)
    Advagen Pharma Ltd
    Usage: Carbidopa and levodopa extended-release tablets are indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism symptoms resulting from carbon monoxide or manganese intoxication.

  • Carbidopa and levodopa (carbidopa and levodopa)

    (CARBIDOPA AND LEVODOPA)
    Sun Pharmaceutical Industries, Inc.
    Usage: Carbidopa and levodopa orally disintegrating tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism after carbon monoxide or manganese intoxication. They allow lower levodopa doses, improve some patients' responses, reduce nausea, and facilitate faster titration of levodopa.

  • Carbidopa and levodopa (carbidopa and levodopa)

    (Carbidopa and Levodopa)
    Coupler LLC
    Usage: Carbidopa and levodopa tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism post carbon monoxide or manganese intoxication. Carbidopa enhances levodopa's effectiveness, lowers required doses, reduces nausea, and allows for quicker titration.

  • Carbidopa and levodopa (carbidopa and levodopa)

    (Carbidopa and Levodopa)
    Cardinal Health 107, LLC
    Usage: Carbidopa and levodopa tablets are indicated for treating Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism due to carbon monoxide or manganese intoxication. Carbidopa allows for lower levodopa doses, improves responses in some patients, and may reduce nausea and vomiting while facilitating faster titration of levodopa.